 Danica Wiredja
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Phosphatase 2 | 4 | 2020 | 41 | 0.940 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2025 | 16 | 0.890 |
Why?
| | HIV-1 | 2 | 2021 | 908 | 0.800 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2025 | 534 | 0.690 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2025 | 673 | 0.670 |
Why?
| | Small Molecule Libraries | 2 | 2018 | 111 | 0.610 |
Why?
| | Phosphoproteins | 3 | 2018 | 337 | 0.590 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2018 | 36 | 0.550 |
Why?
| | Receptors, CCR5 | 1 | 2018 | 60 | 0.540 |
Why?
| | Gene Regulatory Networks | 2 | 2017 | 318 | 0.520 |
Why?
| | HIV Infections | 3 | 2022 | 3195 | 0.480 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2018 | 457 | 0.440 |
Why?
| | Proteomics | 3 | 2018 | 1188 | 0.430 |
Why?
| | Myelodysplastic Syndromes | 2 | 2026 | 165 | 0.390 |
Why?
| | Software | 2 | 2019 | 680 | 0.360 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2018 | 1146 | 0.350 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2026 | 534 | 0.340 |
Why?
| | Sensitivity and Specificity | 3 | 2025 | 2000 | 0.310 |
Why?
| | Enzyme Activators | 3 | 2020 | 9 | 0.300 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 1192 | 0.280 |
Why?
| | Signal Transduction | 3 | 2018 | 5224 | 0.270 |
Why?
| | Brain Diseases, Metabolic, Inborn | 1 | 2026 | 6 | 0.240 |
Why?
| | Succinate Dehydrogenase | 1 | 2026 | 65 | 0.230 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2026 | 28 | 0.230 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2026 | 14 | 0.230 |
Why?
| | Muscle Spasticity | 1 | 2026 | 63 | 0.230 |
Why?
| | ROC Curve | 2 | 2025 | 618 | 0.230 |
Why?
| | Chromosome Aberrations | 1 | 2026 | 166 | 0.220 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2668 | 0.200 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2026 | 224 | 0.200 |
Why?
| | HIV-2 | 1 | 2021 | 18 | 0.180 |
Why?
| | Glioma | 1 | 2026 | 429 | 0.170 |
Why?
| | Nucleocapsid | 1 | 2021 | 19 | 0.170 |
Why?
| | HIV Antibodies | 1 | 2021 | 61 | 0.170 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 129 | 0.160 |
Why?
| | Cell Line, Tumor | 5 | 2020 | 3551 | 0.160 |
Why?
| | Workflow | 1 | 2021 | 183 | 0.150 |
Why?
| | Mutation | 3 | 2026 | 4090 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 126 | 0.150 |
Why?
| | Biomarkers, Tumor | 1 | 2026 | 1329 | 0.140 |
Why?
| | Skin Neoplasms | 1 | 2026 | 853 | 0.140 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2025 | 688 | 0.140 |
Why?
| | Viral Tropism | 1 | 2018 | 36 | 0.140 |
Why?
| | Substrate Specificity | 1 | 2019 | 387 | 0.140 |
Why?
| | Drosophila | 1 | 2019 | 166 | 0.140 |
Why?
| | Protein Phosphatase 2C | 1 | 2018 | 15 | 0.130 |
Why?
| | Receptors, CXCR4 | 1 | 2018 | 91 | 0.130 |
Why?
| | Mass Spectrometry | 2 | 2019 | 732 | 0.130 |
Why?
| | Cell Lineage | 1 | 2019 | 378 | 0.130 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2018 | 53 | 0.130 |
Why?
| | Humans | 16 | 2026 | 145783 | 0.130 |
Why?
| | Antibodies, Viral | 1 | 2021 | 674 | 0.130 |
Why?
| | Cytoskeleton | 1 | 2018 | 192 | 0.130 |
Why?
| | Protein Kinases | 1 | 2019 | 312 | 0.120 |
Why?
| | Immunoglobulin G | 1 | 2021 | 892 | 0.120 |
Why?
| | Gene Ontology | 1 | 2017 | 54 | 0.120 |
Why?
| | Protein Interaction Maps | 1 | 2017 | 51 | 0.120 |
Why?
| | Brain Neoplasms | 1 | 2026 | 1331 | 0.120 |
Why?
| | Phosphorylation | 2 | 2019 | 1708 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 883 | 0.120 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1368 | 0.120 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 254 | 0.120 |
Why?
| | Immunologic Memory | 1 | 2018 | 368 | 0.120 |
Why?
| | Databases, Genetic | 1 | 2017 | 238 | 0.110 |
Why?
| | Virus Replication | 1 | 2018 | 521 | 0.110 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 361 | 0.110 |
Why?
| | Cell Cycle | 1 | 2017 | 598 | 0.100 |
Why?
| | Prevalence | 1 | 2021 | 2875 | 0.100 |
Why?
| | Middle Aged | 6 | 2026 | 36309 | 0.100 |
Why?
| | Computational Biology | 1 | 2019 | 669 | 0.100 |
Why?
| | Algorithms | 1 | 2021 | 1851 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 981 | 0.090 |
Why?
| | Mass Screening | 1 | 2021 | 1361 | 0.090 |
Why?
| | Male | 9 | 2026 | 73011 | 0.090 |
Why?
| | Internet | 1 | 2017 | 693 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1450 | 0.080 |
Why?
| | Genomics | 1 | 2017 | 830 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2017 | 2514 | 0.080 |
Why?
| | Heterografts | 2 | 2020 | 143 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 680 | 0.060 |
Why?
| | Prognosis | 2 | 2026 | 4330 | 0.060 |
Why?
| | Female | 5 | 2026 | 79045 | 0.060 |
Why?
| | Succinic Acid | 1 | 2026 | 46 | 0.060 |
Why?
| | Gene Fusion | 1 | 2026 | 30 | 0.060 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2026 | 72 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2219 | 0.060 |
Why?
| | Karyotyping | 1 | 2025 | 106 | 0.060 |
Why?
| | Animals | 5 | 2020 | 38102 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2019 | 936 | 0.050 |
Why?
| | Clone Cells | 1 | 2025 | 263 | 0.050 |
Why?
| | Adult | 5 | 2026 | 40881 | 0.050 |
Why?
| | Neoplasms | 1 | 2019 | 2913 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2026 | 8347 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 123 | 0.040 |
Why?
| | Protein Binding | 2 | 2019 | 2240 | 0.040 |
Why?
| | Immunoassay | 1 | 2022 | 109 | 0.040 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2021 | 33 | 0.040 |
Why?
| | Area Under Curve | 1 | 2021 | 332 | 0.040 |
Why?
| | Calmodulin-Binding Proteins | 1 | 2019 | 13 | 0.040 |
Why?
| | Lymphatic System | 1 | 2019 | 15 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2026 | 699 | 0.040 |
Why?
| | Wings, Animal | 1 | 2019 | 37 | 0.040 |
Why?
| | Protein Subunits | 1 | 2020 | 229 | 0.040 |
Why?
| | Phosphotransferases | 1 | 2019 | 26 | 0.040 |
Why?
| | Sequence Analysis, Protein | 1 | 2019 | 32 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 849 | 0.040 |
Why?
| | Tyrosine | 1 | 2019 | 217 | 0.040 |
Why?
| | Multiprotein Complexes | 1 | 2020 | 172 | 0.040 |
Why?
| | Databases, Protein | 1 | 2019 | 88 | 0.040 |
Why?
| | Eye | 1 | 2019 | 112 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2019 | 376 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 302 | 0.030 |
Why?
| | Protein Interaction Mapping | 1 | 2019 | 105 | 0.030 |
Why?
| | Arginine | 1 | 2019 | 264 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2019 | 228 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 308 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2020 | 741 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2019 | 265 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 927 | 0.030 |
Why?
| | Universities | 1 | 2019 | 445 | 0.030 |
Why?
| | Mice, SCID | 1 | 2018 | 369 | 0.030 |
Why?
| | Bayes Theorem | 1 | 2019 | 421 | 0.030 |
Why?
| | Receptors, Androgen | 1 | 2018 | 149 | 0.030 |
Why?
| | Research | 1 | 2019 | 431 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2131 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 325 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 592 | 0.030 |
Why?
| | Binding Sites | 1 | 2019 | 1311 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2017 | 762 | 0.030 |
Why?
| | Aged | 2 | 2026 | 26217 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1599 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1478 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 1261 | 0.030 |
Why?
| | Proteome | 1 | 2019 | 513 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1104 | 0.030 |
Why?
| | Students | 1 | 2019 | 652 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3634 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2019 | 1166 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2191 | 0.020 |
Why?
| | Mice | 2 | 2020 | 18356 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2805 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2969 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2021 | 17330 | 0.010 |
Why?
|
|
Wiredja's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|